Thermo Fisher Scientific (TMO)
(Delayed Data from NYSE)
$596.92 USD
+3.13 (0.53%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $596.52 -0.40 (-0.07%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$596.92 USD
+3.13 (0.53%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $596.52 -0.40 (-0.07%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Zacks News
The Zacks Analyst Blog Highlights Thermo Fisher Scientific, Disney, Southern Copper, Tractor Supply and Omnicom
by Zacks Equity Research
Thermo Fisher Scientific, Disney, Southern Copper, Tractor Supply and Omnicom are included in this Analyst Blog.
Top Research Reports for Thermo Fisher Scientific, Walt Disney & Southern Copper
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Thermo Fisher Scientific Inc. (TMO), The Walt Disney Company (DIS) and Southern Copper Corporation (SCCO).
Company News for Apr 25, 2024
by Zacks Equity Research
Companies in The News Are: T,TMO,GD,ETR
Thermo Fisher (TMO) Q1 Earnings Top Estimates, 2024 View Up
by Zacks Equity Research
Thermo Fisher's (TMO) first-quarter 2024 revenues register year-over-year growth driven by new product launches.
Durable Goods Orders Came In Line With Expectations
by Zacks Equity Research
Durable Goods Orders Came In Line With Expectations
Boeing Mixed in Q1, TMO Beats; Durable Goods In-Line
by Mark Vickery
Boeing posted a slimmer loss per share while Thermo Fisher outperformed. Durable Goods performed as expected.
Compared to Estimates, Thermo Fisher (TMO) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Thermo Fisher (TMO) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
What's in Store for These 4 Medical Products Stocks in Q1 Earnings?
by Zacks Equity Research
Medical Products companies' quarterly results are likely to reflect a year-over-year decline in earnings. Let's see how BSX, TMO, ALGN and ICLR fare this time.
Seeking Clues to Thermo Fisher (TMO) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics
by Zacks Equity Research
Evaluate the expected performance of Thermo Fisher (TMO) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
TMO vs. IDXX: Which Stock Is the Better Value Option?
by Zacks Equity Research
TMO vs. IDXX: Which Stock Is the Better Value Option?
What's in Store for Thermo Fisher (TMO) in Q1 Earnings?
by Zacks Equity Research
Strength in Analytical Instrument and Laboratory Products and Services segments are likely to have driven Thermo Fisher's (TMO) first-quarter 2024 performance.
Labcorp's (LH) At-Home Mpox Testing Kit Gets the FDA's EUA Nod
by Zacks Equity Research
Labcorp (LH) receives the FDA's Emergency Use Authorization for the Mpox PCR Test Home Collection Kit.
Waters (WAT) Boosts Waters Operating Segment With HPLC System
by Zacks Equity Research
Waters (WAT) launches Alliance iS Bio HPLC system to improve efficiency across biopharma QC laboratories, boosting its Waters Operating segment.
Charles River (CRL) Forges Collaboration With Ship of Theseus
by Zacks Equity Research
Charles River (CRL) is set to perform plasmid production for Ship of Theseus.
Thermo Fisher (TMO) Launches TSX Universal Series ULT Freezers
by Zacks Equity Research
Thermo Fisher's (TMO) new ENERGY STAR-certified TSX Universal Series ULT Freezers deliver tighter temperature control and faster recovery times.
Thermo Fisher Scientific (TMO) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Thermo Fisher Scientific (TMO) closed the most recent trading day at $579.46, moving +1.55% from the previous trading session.
Thermo Fisher Scientific Inc. (TMO) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Thermo Fisher (TMO) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Thermo Fisher Scientific (TMO) Dips More Than Broader Market: What You Should Know
by Zacks Equity Research
Thermo Fisher Scientific (TMO) reachead $571.56 at the closing of the latest trading day, reflecting a -1.02% change compared to its last close.
Thermo Fisher (TMO) Debuts a New In-Line Metrology Solution
by Zacks Equity Research
Thermo Fisher's (TMO) new LInspector Edge In-line Mass Profilometer delivers real-time, full-coverage mass loading analysis for battery electrode coating.
Here's Why Investors Should Retain Thermo Fisher (TMO) Stock
by Zacks Equity Research
Strength in end markets and strategic collaborations bode well for Thermo Fisher (TMO).
Thermo Fisher Scientific (TMO) Exceeds Market Returns: Some Facts to Consider
by Zacks Equity Research
In the closing of the recent trading day, Thermo Fisher Scientific (TMO) stood at $579.37, denoting a +1.85% change from the preceding trading day.
Thermo Fisher Scientific (TMO) Falls More Steeply Than Broader Market: What Investors Need to Know
by Zacks Equity Research
Thermo Fisher Scientific (TMO) concluded the recent trading session at $568.82, signifying a -0.83% move from its prior day's close.
QIAGEN (QGEN) Partners With IPPA to Raise TB Screening Awareness
by Zacks Equity Research
QIAGEN's (QGEN) collaboration with IPPA follows the updated CDC guidelines for TB screening for immigrants in the United States.
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Thermo Fisher (TMO) Inks Deal to Develop Companion Diagnostics
by Zacks Equity Research
Thermo Fisher's (TMO) new partnership with Bayer AG is likely to help increase the latter's precision cancer therapies.